D. E. Shaw & Co., L.P. 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-02 4:04 pm Purchase | 2026-06-25 | 13G | AGIOS PHARMACEUTICALS INC AGIO | D. E. Shaw & Co., L.P. | 3,034,031 5.100% | 3,034,031 (New Position) | Filing |